Ketones are showing up in two places keto readers care about most: the artery wall and the brain. A June 15 review in Pharmacological Research argues that ketone metabolism may sit at the intersection of atherosclerosis and brain dysfunction, linking inflammation, blood-vessel injury, and fuel failure across both systems. The message is promising, but it is not a claim that keto prevents dementia or heart disease.
Why this review is getting attention
The paper, indexed in PubMed as “Ketone metabolism at the interface of atherosclerosis and brain dysfunction,” takes a systems-level view of how metabolic changes can travel from the liver to the cell. Its keywords tell you exactly where the authors are focused: acetoacetate, atherosclerosis, brain dysfunction, ketogenic diet, ketone body, and -hydroxybutyrate.
That framing matters because ketones are no longer being discussed only as backup fuel during carb restriction. In this review, they are treated as biologically active molecules with possible effects on vascular function, immune behavior, and neuronal resilience. For the keto community, that is a big shift in how the science is being framed.
How heart disease and cognitive decline overlap
The authors argue that atherosclerosis and brain impairment share common biology, especially vascular inflammation, endothelial injury, and energy failure inside the neurovascular unit. In plain terms, the same processes that damage arteries can also make it harder for the brain to get the blood flow and fuel it needs.
That overlap is why ketones are drawing interest in both cardiovascular and neuroscience circles. If blood flow is reduced or glucose metabolism is impaired, the brain may need another usable energy source. If the arterial wall is inflamed and unstable, anything that helps endothelial function and immune balance could matter downstream.
What ketones may be doing in arteries
On the vascular side, the review says ketone bodies such as acetoacetate and D--hydroxybutyrate may improve endothelial function, reduce inflammation, and shift macrophages away from pro-inflammatory states. Those changes are predicted to slow lesion growth and improve plaque stability, which is exactly the kind of language heart researchers use when they are looking at atherosclerosis risk.
This is one reason ketones are getting studied as more than a diet byproduct. The authors are describing them as signals that may influence how blood vessels behave, how immune cells respond, and how plaques develop over time. That does not make them a treatment on their own, but it does make them biologically interesting in a way that goes beyond calorie burning.
What ketones may be doing in the brain
The brain side of the story is just as important. In the review, ketones are described as alternative energy substrates that become especially valuable when blood flow is reduced or glucose metabolism is impaired. That matters in aging, when both vascular supply and cellular glucose handling can become less efficient.
The paper also highlights two deeper mechanisms: mitochondrial support and epigenetic effects. Those pathways point to synaptic resilience, the ability of neurons and their connections to keep working under stress, which is central to cognition and neuronal survival. In other words, ketones are being studied not only as fuel, but as part of the machinery that helps the brain stay functional.
Why this is not a blanket keto endorsement
The authors are explicit that translation into practice will require personalization. Genetic and metabolic variability may change who benefits, who does not, and who may even respond poorly in certain settings. That is a far cry from the idea that everyone should chase ketones as the same solution for every heart or brain problem.
A related 2026 review in MDPI’s Cells reinforces that point. It also treats ketones as active signaling molecules and calls out -hydroxybutyrylation, a post-translational modification that may affect the fate and function of target proteins. That review also notes therapeutic challenges and possible gender- and age-specific differences in ketone treatment, which makes the field look more nuanced, not less.
How this fits with mainstream heart guidance
This mechanistic literature is advancing at the same time that mainstream cardiovascular guidance remains cautious. On January 7, 2026, the American Heart Association said it welcomed the 2025-2030 Dietary Guidelines for Americans and emphasized its longstanding advice for heart-healthy eating. That stance stays aligned with broader prevention guidance that still favors patterns built around plants, lean proteins, and lower saturated fat.
The National Heart, Lung, and Blood Institute’s DASH eating plan reflects that same approach. It recommends vegetables, fruits, whole grains, fat-free or low-fat dairy, fish, poultry, beans, nuts, and vegetable oils, while limiting foods high in saturated fat and tropical oils such as coconut, palm kernel, and palm oils. For keto followers, that is the key tension: the science is exploring ketones as signals, but public-health guidance still centers on overall dietary quality and saturated-fat control.
Why caution keeps showing up in keto heart debates
That caution is not coming out of nowhere. An American College of Cardiology report from March 5, 2023 said a keto-like diet was associated with higher LDL cholesterol and about a twofold heightened risk of cardiovascular events in the study presented. Harvard Health later summarized a 2024 review as warning that keto may raise heart disease risk and may not be safe for some people with heart disease.
At the same time, the research landscape is not one-note. A 2025-2026 body of cardiovascular literature continues to explore ketone therapy as potentially helpful in some settings while stressing unresolved therapeutic challenges. A 2026 Frontiers review on cognition makes a similar point from the brain side, saying ketone bodies can serve as an alternative cerebral fuel and may also have signaling effects relevant to cognition across healthy and clinical populations.
The bigger takeaway for keto readers
This is where the story lands: ketones are increasingly being studied as a common metabolic lever for two major age-related disease categories that often travel together. The review’s real value is not in promising a cure, but in showing why ketones keep appearing in both heart and brain conversations.
For anyone following keto, that is the useful takeaway. The science is moving from a simple fuel story to a bigger picture of vascular health, inflammation, and cellular energy, and that makes ketones worth watching closely even as the case for clinical use stays careful and patient-specific.
Every story on Keto Diet Magazine is assembled by an automated editorial system that works from verified research, official records, and credible reporting, then clears automated accuracy and moderation checks before it goes live. The standards that system follows are set and overseen by the people who run the publication. Read our full editorial policy.
Know something we missed? Have a correction or additional information?
Submit a Tip
